Alexander B Olawaiye, Md

This study tests a new combination of drugs for people with ovarian cancer that has come back and no longer responds to platinum-based chemotherapy. The treatment adds a drug called ALX148 to standard chemotherapy and an immunotherapy drug, aiming to help the immune system attack…